ITBO910163A1 - Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. - Google Patents

Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.

Info

Publication number
ITBO910163A1
ITBO910163A1 IT000163A ITBO910163A ITBO910163A1 IT BO910163 A1 ITBO910163 A1 IT BO910163A1 IT 000163 A IT000163 A IT 000163A IT BO910163 A ITBO910163 A IT BO910163A IT BO910163 A1 ITBO910163 A1 IT BO910163A1
Authority
IT
Italy
Prior art keywords
diabetic
glycosaminoglicans
treatment
neuropathy
nephropathy
Prior art date
Application number
IT000163A
Other languages
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Original Assignee
Alfa Wassermann Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann Spa filed Critical Alfa Wassermann Spa
Priority to ITBO910163A priority Critical patent/IT1245907B/it
Publication of ITBO910163A0 publication Critical patent/ITBO910163A0/it
Priority to EP92105692A priority patent/EP0513513B1/en
Priority to DE69212620T priority patent/DE69212620T2/de
Priority to US07/871,048 priority patent/US5236910A/en
Priority to CA002066785A priority patent/CA2066785C/en
Priority to KR1019920008367A priority patent/KR970005181B1/ko
Publication of ITBO910163A1 publication Critical patent/ITBO910163A1/it
Application granted granted Critical
Publication of IT1245907B publication Critical patent/IT1245907B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
ITBO910163A 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica. IT1245907B (it)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ITBO910163A IT1245907B (it) 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
EP92105692A EP0513513B1 (en) 1991-05-17 1992-04-02 Use of glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy
DE69212620T DE69212620T2 (de) 1991-05-17 1992-04-02 Verwendung von Glycosaminoglycanen zur Behandlung von diabetischer Nephropathie und diabetischer Neuropathie
US07/871,048 US5236910A (en) 1991-05-17 1992-04-20 Use of glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy
CA002066785A CA2066785C (en) 1991-05-17 1992-04-22 Glycosaminoglycans in the treatment of diabetic nephropathy and diabetic neuropathy
KR1019920008367A KR970005181B1 (ko) 1991-05-17 1992-05-18 글리코스아미노글리칸을 주성분으로 하는 당뇨병 치료제

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910163A IT1245907B (it) 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.

Publications (3)

Publication Number Publication Date
ITBO910163A0 ITBO910163A0 (it) 1991-05-17
ITBO910163A1 true ITBO910163A1 (it) 1992-11-17
IT1245907B IT1245907B (it) 1994-10-25

Family

ID=11337489

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910163A IT1245907B (it) 1991-05-17 1991-05-17 Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.

Country Status (6)

Country Link
US (1) US5236910A (it)
EP (1) EP0513513B1 (it)
KR (1) KR970005181B1 (it)
CA (1) CA2066785C (it)
DE (1) DE69212620T2 (it)
IT (1) IT1245907B (it)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1264530B (it) * 1992-07-31 1996-10-02 Crinos Industria Farmaco Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
US5696100A (en) * 1992-12-22 1997-12-09 Glycomed Incorporated Method for controlling O-desulfation of heparin and compositions produced thereby
IT1270846B (it) * 1993-05-10 1997-05-13 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
IT1271685B (it) * 1994-08-03 1997-06-04 Crinos Industria Farmaco Impiego dei polidesossiribonucleotidi nelle neuropati diabetiche
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
US5763427A (en) * 1995-03-31 1998-06-09 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US6001820A (en) * 1995-03-31 1999-12-14 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5744457A (en) * 1995-03-31 1998-04-28 Hamilton Civic Hospitals Research Development Inc. Compositions and methods for inhibiting thrombogenesis
US5767269A (en) * 1996-10-01 1998-06-16 Hamilton Civic Hospitals Research Development Inc. Processes for the preparation of low-affinity, low molecular weight heparins useful as antithrombotics
DE29900874U1 (de) 1999-01-20 1999-07-22 Knoll Ag Organprotektive Lösungen
US6083933A (en) * 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US6562836B1 (en) * 1999-05-24 2003-05-13 Queen's University Of Kingston Methods and compounds for inhibiting amyloid deposits
MXPA02000142A (es) * 1999-06-30 2003-07-21 Hamilton Civic Hospitals Res Composiciones de heparina que inhiben los factores de coagulacion asociados con el coagulo.
AU5908300A (en) * 1999-07-01 2001-01-22 Eli Lilly And Company Prevention and treatment of amyloid-associated disorders
US7259152B2 (en) 2000-06-07 2007-08-21 Alfa Wasserman, Inc. Methods and compositions using sulodexide for the treatment of diabetic nephropathy
WO2002020091A2 (en) * 2000-09-08 2002-03-14 Hamilton Civic Hospitals Research Development Inc. Antithrombotic compositions
CA2449962A1 (en) * 2001-06-12 2002-12-19 Noa Shelach Use of glycosaminoglycans for the treatment of hiv-associated nephropathy
US20040161476A1 (en) 2003-02-19 2004-08-19 Hahn Sungtack Samuel Cystitis treatment with high dose chondroitin sulfate
CA2519681A1 (en) * 2003-03-28 2004-10-07 Applied Research Systems Ars Holding N.V. Use of clusterin for the treatment and/or prevention of peripheral neurological diseases
AU2005292202A1 (en) * 2004-10-01 2006-04-13 Keryx Biopharmaceuticals, Inc. Methods using glycosaminoglycans for the treatment of kidney disease
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
DE102005017799A1 (de) * 2005-04-18 2006-10-19 Abbott Gmbh & Co. Kg Verwendung von Heparin und Heparinderivaten zur Modulation des Neuritenwachstum-kontrollierenden Nogo-Rezeptors
JP5622346B2 (ja) * 2006-05-19 2014-11-12 愛知県 神経細胞の細胞死抑制剤等
ITMI20061692A1 (it) 2006-09-05 2008-03-06 Alfa Wassermann Spa Uso di polioli per ottenere forme polimorfe stabili di rifaximina
GB0714500D0 (en) * 2007-07-25 2007-09-05 Hunter Fleming Ltd composition and treatment
CN101632686A (zh) * 2008-04-04 2010-01-27 马斯特里赫特大学 糖胺聚糖用于修复糖萼的用途
ES2340902B1 (es) * 2008-07-01 2011-05-03 Laboratorios Farmaceuticos Rovi, S.A. Composicion farmaceutica con glicosaminoglicanos y su uso en tratamiento de ulceras cronicas.
JP2013522172A (ja) * 2010-03-12 2013-06-13 ジ オーストラリアン ナショナル ユニバーシティ ヘパラン硫酸補充療法
IT1401253B1 (it) * 2010-04-23 2013-07-18 Uni Degli Studi Carlo Bo Urbino Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990000058A1 (de) * 1988-06-27 1990-01-11 Roland Reiner Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie

Also Published As

Publication number Publication date
DE69212620T2 (de) 1996-11-28
DE69212620D1 (de) 1996-09-12
ITBO910163A0 (it) 1991-05-17
EP0513513A1 (en) 1992-11-19
CA2066785A1 (en) 1992-11-18
EP0513513B1 (en) 1996-08-07
US5236910A (en) 1993-08-17
KR970005181B1 (ko) 1997-04-14
KR920021153A (ko) 1992-12-18
CA2066785C (en) 1999-01-12
IT1245907B (it) 1994-10-25

Similar Documents

Publication Publication Date Title
ITBO910163A1 (it) Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
MX9204301A (es) Acilmercaptoalcanoildipeptidos, metodos de preparacion y su uso terapeutico.
DE69022506T2 (de) Saugfähiges Gewebegebilde und Gebrauch desselben.
DE68924477D1 (de) Gleitkommaeinheit mit gleichzeitiger Multiplikation und Addition.
DE59004453D1 (de) Farbstoffmischung und deren Verwendung.
DE3780625T2 (de) Rolleneinheit und kombinierte zylinder.
MX151696A (es) Mejoras en construccion que incluye una unidad de fuente de gas,para uso en camas ajustables y lo similar
TR28384A (tr) Flüoroalifatik -ve karboksil- iceren terminal gruplarina sahip polisilokzanlar, bunlarin hazirlanmasi, ve lifli malzemelerin muamelesinde kullanimlari.
FI944600A (fi) Imidatsol-4-yylipiperidiinijohdannaisia, niiden valmistus ja niiden käyttö terapiassa
DE68907723D1 (de) Holzstruktur und rollenpresse dazu.
MX9201681A (es) 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas.
DE68910113D1 (de) Wachstuminhibierendes mittel und dessen verwendung.
ITBO930205A0 (it) Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della nefropatia diabetica.
DE58902272D1 (de) Substituierte naphthacen-5,12-dione und deren verwendung.
DE59009878D1 (de) Farbstoffmischungen und deren Verwendung.
MX9200431A (es) Azapironas:el uso en el desorden de hiperactividad de la falta de atencion.
ITMI912509A1 (it) Uso della nimesulide nel trattamento della cataratta
DE69011337D1 (de) Polyhalodihydrodioxine und polyhalodioxole.
ATE111292T1 (de) Heizen von lagern und dergleichen.
ITMI911146A1 (it) Agente antiarteriosclerotico, sua preparazione ed uso
ITMI941064A0 (it) Uso della s-benzoilossimetiltiamina nel trattamento del diabete
MX18585A (es) Compuestos de pirrol y su uso.
DE59008017D1 (de) Farbstoffmischungen und deren Verwendung.
DE59007243D1 (de) Farbstoffmischungen und deren Verwendung.
IT1302920B1 (it) Uso della propoli nel trattamento della vitiligine e della psoriasi.

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423